Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis - Poll - MDSpire

Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis

  • By

  • Stephen Weidinger

  • Kristian Reich

  • Naiem Issa

  • H. Chih-ho Hong

  • Christopher G. Bunick

  • Pinaki Biswas

  • Gary Chan

  • Erman Güler

  • Melissa Watkins

  • Justine Alderfer

  • June 27, 2026

  • 0 min

Share

Original Source(s)

Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis

  • by Stephen Weidinger, Kristian Reich, Naiem Issa, H. Chih-ho Hong, Christopher G. Bunick, Pinaki Biswas, Gary Chan, Erman Güler, Melissa Watkins, Justine Alderfer

  • June 27, 2026

Related Content

Extracellular vesicles in atopic dermatitis: unraveling pathogenic mediators and engineering therapeutic vectors

Psoriasis–AD Switching May Mimic Treatment Failure

Recognizing sustained switches between the two diseases can prevent premature discontinuation of effective biologics and point toward Janus kinase inhibitors, a 148-patient cohort suggests.

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice